← Return to Aromatase Inhibitors: Did you decide to go on them or not?
DiscussionAromatase Inhibitors: Did you decide to go on them or not?
Breast Cancer | Last Active: May 12, 2023 | Replies (1190)Comment receiving replies
Replies to "Thank you for this and all you contribute here. I agreed with thr oncologist going forward...."
ps The Tailor X study was to help women with intermediate Oncotype DX scores decide on whether to have chemo or not. Low scores and high scores had a more clear path.
"Women in the trial who had a score in the intermediate range (11–25) were randomly assigned to receive hormone therapy alone or hormone therapy with adjuvant chemotherapy. The goal was to assess whether women who received hormone therapy alone had outcomes that were as good as those among women who received chemotherapy in addition to hormone therapy." https://www.cancer.gov/news-events/press-releases/2018/tailorx-breast-cancer-chemotherapy
The study supported the use of hormonal meds only, without chemo, for these patients. "According to the authors, the new findings suggest that chemotherapy may be avoided in about 70 percent of women with HR-positive, HER2-negative, node-negative breast cancer." All participants were on hormonal meds.